¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"methyl red"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • red degeneration
    Àû»öº¯¼º(îåßäܨàõ)
  • red eye
    »¡°£´«, ÃæÇ÷¾È
  • red fiber
    Àû»ö¼¶À¯, Àû¼¶À¯(îåàéë«).
  • red glass test
    Àû±Û¶ó½º½ÃÇè.
  • red green visual substance
    Àû·Ï(»ö)½Ã°¢ ¹°Áú.
  • red hepatization
    Àû»ö°£º¯(îåßäÊÜܨ)
  • red hypertension
    È«Á¶¼º °íÇ÷¾ÐÁõ(ûõðÍàõÍÔúìäâñø).
  • red hypertension
    È«Á¶¼º °íÇ÷¾ÐÁõ(ûõðÍàõÍÔúìäâñø)
  • red induration
    Àû»ö°æÈ­(îåßäÌãûù)
  • red infarct
    Àû»ö°æ»ö(îåßäÌÛßá)
  • red lead
    ¿¬´Ü(æçÕ®).
  • red mark
    Àû(»ö)ºñ¼ö(îåßäÞ¡âÐ).
  • red marrow
    Àû»ö°ñ¼ö, Àû°ñ¼ö(îåÍéâÐ).
  • red marrow
    Àû»ö°ñ¼ö (Àû»ö»À¼ÓÁú)
  • red migraine
    ¹ßÀûÆíµÎÅë(Û¡îåø¶Ôé÷Ô).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • pure red cell anemia
    (ÁøÁ¤)ÀûÇ÷±¸°è ºóÇ÷((òØïá)îåúìϹͧ Þ¸úì)
  • pure red cell aplasia
    (ÁøÁ¤)ÀûÇ÷±¸°è ¹«Çü¼º(Áõ)(¡­Ùíû¡à÷ñø).
  • pure red cell aplasia
    (ÁøÁ¤)ÀûÇ÷±¸°è ¹«Çü¼º(Áõ)((òØïá)îåúìϹͧ Ùíû¡à÷ñø)
  • ragged red fiber
    Àû³³±Ù ¼¶À¯(îåÒ¤ÐÉ àéë«)
  • ragged red fibers
    ºÒ±ÕÀÏÀû»ö±Ù¼¶À¯(ÝÕгìéîåßäÐÉàéë«)
  • red anomaly
    Àû»ö¾à(îåßäå°), Àû»ö°¢ÀÌ»ó.
  • red atrophy
    Àû»öÀ§Ãà(îåßäê×õê)
  • red blood cell
    ÀûÇ÷±¸
  • red blood cell cast
    ÀûÇ÷±¸¿øÁÖ
  • red blood cell destruction
    ÀûÇ÷±¸ºØ±«(îåúìϹÝÚÎÕ)
  • red blood cell pasta
    ÀûÇ÷±¸È£Á¦(¡­ûÕð¥).
  • red blood cell survival test
    ÀûÇ÷±¸¼ö¸í½ÃÇè(îåúìϹáøÙ¤ãËúÐ).
  • red blood cell=RBC
    ÀûÇ÷±¸
  • red blood corpuscle
    ÀûÇ÷±¸.
  • red bone marrow
    Àû»ö°ñ¼ö(îåßäÍéâÐ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
CMO Corticosteroid Methyl-Oxidase
COMT Catechol-O-Methyl Transferase
DMT Di-Methyl-Triptamine
DOM Dimeth-Oxy-Methyl amphetamine
MTBE Methyl-Tert-Butyl Ether
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
IR Infra-red
ICRC International Committee of the Red Cross
MCV Mean red cell volume
MERRF Myoclonic Epilepsy and Ragged Red Fibers
MERRF Myoclonic epilepsy with ragged-red fibers
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
NADH-methyl viologen reductase <enzyme> Fad-protein from rhodospirillum rubrum which also reduces methylene blue and 2,6-dichlorophenol-indophenol
Registry number: EC 1.6.-
(26 Jun 1999)
ng-nitroarginine methyl ester <chemical> A non-selective inhibitor of nitric oxide synthase. It has been used experimentally to induce hypertension.
Pharmacological action: enzyme inhibitors.
(12 Dec 1998)
n-methyl-3,4-methylenedioxyamphetamine <chemical> An n-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as mdma or ecstasy.
Pharmacological action: adrenergic uptake inhibitors, hallucinogens, serotonin agents.
Chemical name: 1,3-Benzodioxole-5-ethanamine, N,alpha-dimethyl-
(12 Dec 1998)
N methyl D aspartate receptor <physiology> Glutamate receptor sub type (see excitatory amino acids). N methyl D aspartate receptor channels seem to be potentiated by intracellular arachidonic acid.
Acronym: NMDA
(26 Mar 1998)
N-methyl, D-aspartic acid n methyl D aspartate receptor
isoprenylcysteine methyl ester hydrolase <enzyme> Acts on proteins post-translationally isoprenylated on a cysteine 3 amino acids in from the carboxy terminus, followed by carboxymethylation
Registry number: EC 3.1.1.-
Synonym: isoprenylcys methylase
(26 Jun 1999)
tosylarginine methyl ester <chemical> N(2)-(p-tolylsulfonyl)-l-arginine, methyl ester. Arginine derivative which is a substrate for many proteolytic enzymes. As a substrate for the esterase from the first component of complement, it inhibits the action of c(l) on c(4).
Chemical name: L-Arginine, N2-((4-methylphenyl)sulfonyl)-, methyl ester
(12 Dec 1998)
tosylarginine methyl ester hydrolase <enzyme> Protease from sea urchin (arbacia punctulata) eggs; fertilization in the sea urchin is accompanied by the release of this protease from eggs into the surrounding seawater; enzyme uses tame as substrate; used as a measure of trypsin-like activity; tryptase (formerly here) is mast cell tryptase (EC 3.4.21.59)
Registry number: EC 3.4.-
Synonym: tame hydrolase, tame esterase, esterase a2, n-tosyl-l-arginine methyl ester esterase, tamase, tamase-1
(26 Jun 1999)
1-methyl-3-isobutylxanthine <chemical> 3,7-dihydro-1-methyl-3-(2-methylpropyl)-1h-purine-2,6-dione. A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates cyclic nucleotide-dependent protein kinases.
Pharmacological action: phosphodiesterase inhibitors.
Chemical name: 1H-Purine-2,6-dione, 3,7-dihydro-1-methyl-3-(2-methylpropyl)-
(12 Dec 1998)
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine <chemical> 1,2,3,6-tetrahydro-1-methyl-4-phenylpyridine. A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in parkinson disease. These toxic effects can be prevented by the administration of selective monoamine oxidase inhibitors. Since the cellular toxicity of the compound is similar to that observed in idiopathic parkinson disease, experimental studies with this compound can suggest new opportunities for effective therapy. The compound also induces duodenal ulcers.
Pharmacological action: dopamine agents.
Chemical name: Pyridine, 1,2,3,6-tetrahydro-1-methyl-4-phenyl-
(12 Dec 1998)
1-methyl-4-phenylpyridinium <chemical> 1-methyl-4-phenylpyridinium (mpp+). An active neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (mptp). The compound reduces dopamine levels, inhibits the biosynthesis of catecholamines, depletes cardiac norepinephrine and inactivates tyrosine hydroxylase. These and other toxic effects lead to cessation of oxidative phosphorylation, ATP depletion, and cell death. The compound, which is related to paraquat, has also been used as an herbicide.
Pharmacological action: dopamine agents, herbicides.
Chemical name: Pyridinium, 1-methyl-4-phenyl-
(12 Dec 1998)
2-methyl branched-chain enoyl-CoA reductase <enzyme> Important in the reversal of beta-oxidation under anaerobic conditions in ascaris suum
Registry number: EC 1.3.1.52
Synonym: 2-methyl bce-CoA reductase
(26 Jun 1999)
3-(2,4--dioxo-6-methyl-5-pyrimidinyl)acrylic acid synthase <enzyme> Involved in sparsomycin biosynthesis; catalyses conversion of 3-(4-oxo-6-methyl-5-pyrimidinyl)acrylic acid to 3-(2,4-dioxo-6-methyl-5-pyrimidinyl)acrylic acid
Registry number: EC 1.14.13.-
Synonym: (e)-uca synthase
(26 Jun 1999)
(3-(5-methyl-2-thienyl)acryloyl)chymotrypsin Pharmacological action: indicator and reagent
Synonym: 3-mtac
(26 Jun 1999)
3-methyl-2-oxobutanoate hydroxymethyltransferase <enzyme> Methylenetetrahydrofolate and alpha-ketoisovalerate gives tetrahydrofolate and ketopantoate
Chemical name: 5,10-methylenetetrahydrofolate alpha-ketoisovalerate hydroxymethyltransferase
Registry number: EC 2.1.2.11
Synonym: iphm transferase, panb protein, ketopantoate hydroxymethyltransferase
(26 Jun 1999)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • red balloon
    ·¹µå ¹ú·é(À§±â °æ°íÀÇ Ç¥Áö)
  • red bark
    ±â³ª¼öÀÇ ¾à¿ë ²®Áú
  • red beet
    ±Ù´ëÀÇ ÀÏÁ¾
  • red blood cell(corpuscle)
    ÀûÇ÷±¸
  • red box
    Àå°üÀÇ °ø¿ë ¼­·ùÇÔ
  • red brass
    Àû»ö Ȳµ¿
  • red carpet
    (°í°üÀÇ ÃâÀԷο¡ ±î´Â)ºÓÀº À¶´Ü;±ØÁøÇÑ ¿¹¿ì(´ëÁ¢,ȯ¿µ)
  • red cedar
    ¿¬ÇÊÇâ ³ª¹«(ºÏ¹Ì µ¿ºÎ ¿ø»ê.¿¬ÇÊ.ħ¸ñ.°¡±¸¿ë);¹Ì±¹ Ãø¹é(ºÏ¹Ì¼­ºÎ»ê)
  • red cell
    =REC BLOOD CELL
  • red cent
    ¼¾Æ® µ¿Àü(Àü¿¡´Â ¼ø µ¿ÀüÀ¸·Î ºÓÀº »öÀ̾úÀ½)
  • red chicken
    »ýÇì·ÎÀÎ(ºÒ¼ø¹°ÀÌ ¸¹ÀÌ µç)
  • red clover
    ºÓÀº Å䳢Ǯ
  • red corpuscle (corpuscule)
    ÀûÇ÷±¸
  • red deer
    ºÓÀº »ç½¿(À¯¶ó½Ã¾Æ ´ë·ú»ê);Èò²¿¸® »ç½¿(¹Ì±¹ ¹× ³²¹Ì ºÏºÎ»ê)
  • red devil
    ¼¼ÄÚ¹Ù¸£ºñÅ»ÀÇ »¡°£ ĸ½¶;¿µ±¹ À°±º ÆÄ¶ó½´Æ® ¿¬´ë
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á